Advertisement intended for health care professionals

l

Flow cytometry–based evaluation of TRBC1/TRBC2 facilitates identification of indolent T-lymphoblastic proliferations

Flow cytometry–based evaluation of TRBC1/TRBC2 facilitates identification of indolent T-lymphoblastic proliferations
#00066221
Author: Xiaoming Fan; Qian Xi
Category: Lymphoma: Mature B-cell and Plasma cell Neoplasms > Virus-associated lymphoproliferations > HHV8-associated lymphoproliferative disorders > Multicentric Castleman Disease (MCD)
Published Date: 02/10/2026

A 51-year-old woman with Castleman disease presented with fatigue, dizziness, lymphadenopathy, and pancytopenia. A bone marrow smear and flow cytometry showed no abnormalities. Histopathologic examination of the left cervical and inguinal lymph nodes was consistent with multicentric Castleman disease with interfollicular infiltration of small-to-medium lymphocytes without atypia (panel A-B; hematoxylin and eosin stain of the inguinal lymph node biopsy; 20× objective for panel A; 40× objective for panel B). Immunohistochemistry revealed that these lymphocytes expressed CD3 (panel C; 40× objective), CD5, CD4, CD8, partial CD99× (panel D; 40× objective), and partial terminal deoxynucleotidyl transferase (panel E; 40× objective). Flow cytometric evaluation of the biopsy samples revealed ∼40% immature T lymphoblasts that exhibited a cortical thymocyte-like immunophenotype (cyCD3+sCD3partial+CD4+CD8+CD1a+CD5dim+CD7dim+CD2+CD99+). Polytypic expression of surface (s) T-cell receptor β chain constant region 1 (TRBC1)/sTRBC2 and cytoplasmic (cy) TRBC1/cyTRBC2 were observed in sCD3-positive lymphoblasts and all cyCD3-positive lymphoblasts, respectively (panel F). No clonal T-cell receptor gene rearrangement was detected by polymerase chain reaction. Collectively, these findings established a diagnosis of indolent T-lymphoblastic proliferation (iT-LBP) associated with multicentric Castleman disease. The patient received siltuximab-based therapy for more than 1 year without disease progression.

iT-LBP is a rare entity with immunophenotypes that resemble an intermediate stage of thymocyte development and mimic cortical T-lymphoblastic leukemia/lymphoma. To date, no previous studies have documented the expression pattern of TRBC1/TRBC2 in iT-LBP. This case highlights the use of flow cytometry–based evaluation of TRBC1/TRBC2 to confirm T-cell polyclonality and identify iT-LBP.

For additional images, visit the ASH Image Bank, a reference and teaching tool that is continually updated with new atlas and case study images. For more information, visit https://imagebank.hematology.org.

Advertisement intended for health care professionals